Drug shortages

Rivastigmine Film, Extended Release

Mylan Pharmaceuticals Inc., a Viatris Company

To Be Discontinued0378-9070-93Neurology
Open FDA's page for this record
Discontinued date
09/18/2026
Update type
New
Initial posting date
09/18/2026
Package NDC
0378-9070-93
Generic name
Rivastigmine Film, Extended Release
Contact info
800-796-9526
Related info
Discontinuation of the manufacture of the drug.
Update date
09/18/2026
Dosage form
Film, Extended Release
Presentation
Rivastigmine, Film, Extended Release, 4.6 mg/24 h (NDC 0378-9070-93)
Company name
Mylan Pharmaceuticals Inc., a Viatris Company
Status
To Be Discontinued
Therapeutic category
Neurology
Harmonized identifiers (openFDA)
Application number
ANDA205622
Brand name
RIVASTIGMINE
Generic name
RIVASTIGMINE
Manufacturer name
Mylan Pharmaceuticals Inc.
Product NDC
0378-9070, 0378-9071, 0378-9072
Product type
HUMAN PRESCRIPTION DRUG
Route
TRANSDERMAL
Substance name
RIVASTIGMINE
RxCUI
725021, 725023, 1308569
SPL ID
c1d8c8a9-87e9-4ca1-ba70-4a7467205fd4
SPL set ID
4ab335d1-19ee-4cd9-9776-8086645d19e4
Package NDC
0378-9070-16, 0378-9070-93, 0378-9071-16, 0378-9071-93, 0378-9072-16, 0378-9072-93
Nui
N0000175723, N0000000177
Pharm class epc
Cholinesterase Inhibitor [EPC]
Pharm class moa
Cholinesterase Inhibitors [MoA]
UNII
PKI06M3IW0
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.